Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Creating a web-based electronic tool to aid tuberculosis (TB) cluster investigation: data integration in TB surveillance activities in the United Kingdom, 2013 to 2016.

Davidson JA, Anderson LF, Adebisi V, de Jongh L, Burkitt A, Lalor MK.

Euro Surveill. 2018 Nov;23(44). doi: 10.2807/1560-7917.ES.2018.23.44.1700794.

2.

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.

Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017, Ahmad N, Ahuja SD, Akkerman OW, Alffenaar JC, Anderson LF, Baghaei P, Bang D, Barry PM, Bastos ML, Behera D, Benedetti A, Bisson GP, Boeree MJ, Bonnet M, Brode SK, Brust JCM, Cai Y, Caumes E, Cegielski JP, Centis R, Chan PC, Chan ED, Chang KC, Charles M, Cirule A, Dalcolmo MP, D'Ambrosio L, de Vries G, Dheda K, Esmail A, Flood J, Fox GJ, Fréchet-Jachym M, Fregona G, Gayoso R, Gegia M, Gler MT, Gu S, Guglielmetti L, Holtz TH, Hughes J, Isaakidis P, Jarlsberg L, Kempker RR, Keshavjee S, Khan FA, Kipiani M, Koenig SP, Koh WJ, Kritski A, Kuksa L, Kvasnovsky CL, Kwak N, Lan Z, Lange C, Laniado-Laborín R, Lee M, Leimane V, Leung CC, Leung EC, Li PZ, Lowenthal P, Maciel EL, Marks SM, Mase S, Mbuagbaw L, Migliori GB, Milanov V, Miller AC, Mitnick CD, Modongo C, Mohr E, Monedero I, Nahid P, Ndjeka N, O'Donnell MR, Padayatchi N, Palmero D, Pape JW, Podewils LJ, Reynolds I, Riekstina V, Robert J, Rodriguez M, Seaworth B, Seung KJ, Schnippel K, Shim TS, Singla R, Smith SE, Sotgiu G, Sukhbaatar G, Tabarsi P, Tiberi S, Trajman A, Trieu L, Udwadia ZF, van der Werf TS, Veziris N, Viiklepp P, Vilbrun SC, Walsh K, Westenhouse J, Yew WW, Yim JJ, Zetola NM, Zignol M, Menzies D.

Lancet. 2018 Sep 8;392(10150):821-834. doi: 10.1016/S0140-6736(18)31644-1. Review.

PMID:
30215381
3.

The use of whole-genome sequencing in cluster investigation of a multidrug-resistant tuberculosis outbreak.

Lalor MK, Casali N, Walker TM, Anderson LF, Davidson JA, Ratna N, Mullarkey C, Gent M, Foster K, Brown T, Magee J, Barrett A, Crook DW, Drobniewski F, Thomas HL, Abubakar I.

Eur Respir J. 2018 Jun 21;51(6). pii: 1702313. doi: 10.1183/13993003.02313-2017. Print 2018 Jun.

PMID:
29748309
4.

Investigating a tuberculosis cluster among Filipino health care workers in a low-incidence country.

Davidson JA, Fulton N, Thomas HL, Lalor MK, Zenner D, Brown T, Murphy S, Anderson LF.

Int J Tuberc Lung Dis. 2018 Mar 1;22(3):252-257. doi: 10.5588/ijtld.17.0620.

PMID:
29471901
5.

Recent household transmission of tuberculosis in England, 2010-2012: retrospective national cohort study combining epidemiological and molecular strain typing data.

Lalor MK, Anderson LF, Hamblion EL, Burkitt A, Davidson JA, Maguire H, Abubakar I, Thomas HL.

BMC Med. 2017 Jun 13;15(1):105. doi: 10.1186/s12916-017-0864-y.

6.

Health system factors influencing management of multidrug-resistant tuberculosis in four European Union countries - learning from country experiences.

de Vries G, Tsolova S, Anderson LF, Gebhard AC, Heldal E, Hollo V, Cejudo LS, Schmid D, Schreuder B, Varleva T, van der Werf MJ.

BMC Public Health. 2017 Apr 19;17(1):334. doi: 10.1186/s12889-017-4216-9.

7.

Recent TB transmission, clustering and predictors of large clusters in London, 2010-2012: results from first 3 years of universal MIRU-VNTR strain typing.

Hamblion EL, Le Menach A, Anderson LF, Lalor MK, Brown T, Abubakar I, Anderson C, Maguire H, Anderson SR; Public Health England Strain Typing Project Board.

Thorax. 2016 Aug;71(8):749-56. doi: 10.1136/thoraxjnl-2014-206608.

8.

Pulmonary Mycobacterium avium-intracellulare is the main driver of the rise in non-tuberculous mycobacteria incidence in England, Wales and Northern Ireland, 2007-2012.

Shah NM, Davidson JA, Anderson LF, Lalor MK, Kim J, Thomas HL, Lipman M, Abubakar I.

BMC Infect Dis. 2016 May 6;16:195. doi: 10.1186/s12879-016-1521-3.

9.

Leprosy in England and Wales 1953-2012: surveillance and challenges in low incidence countries.

Fulton N, Anderson LF, Watson JM, Abubakar I.

BMJ Open. 2016 May 3;6(5):e010608. doi: 10.1136/bmjopen-2015-010608.

10.

Mind the gap: TB trends in the USA and the UK, 2000-2011.

Nnadi CD, Anderson LF, Armstrong LR, Stagg HR, Pedrazzoli D, Pratt R, Heilig CM, Abubakar I, Moonan PK.

Thorax. 2016 Apr;71(4):356-63. doi: 10.1136/thoraxjnl-2015-207915. Epub 2016 Feb 23.

11.

TB in healthcare workers in the UK: a cohort analysis 2009-2013.

Davidson JA, Lalor MK, Anderson LF, Tamne S, Abubakar I, Thomas HL.

Thorax. 2017 Jul;72(7):654-659. doi: 10.1136/thoraxjnl-2015-208026. Epub 2016 Feb 17.

PMID:
26888779
12.

Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK, 2007-12, with whole pathogen genome sequences: an observational study.

Walker TM, Lalor MK, Broda A, Ortega LS, Morgan M, Parker L, Churchill S, Bennett K, Golubchik T, Giess AP, Del Ojo Elias C, Jeffery KJ, Bowler ICJW, Laurenson IF, Barrett A, Drobniewski F, McCarthy ND, Anderson LF, Abubakar I, Thomas HL, Monk P, Smith EG, Walker AS, Crook DW, Peto TEA, Conlon CP.

Lancet Respir Med. 2014 Apr;2(4):285-292. doi: 10.1016/S2213-2600(14)70027-X. Epub 2014 Mar 4.

13.

Transmission of multidrug-resistant tuberculosis in the UK: a cross-sectional molecular and epidemiological study of clustering and contact tracing.

Anderson LF, Tamne S, Brown T, Watson JP, Mullarkey C, Zenner D, Abubakar I.

Lancet Infect Dis. 2014 May;14(5):406-15. doi: 10.1016/S1473-3099(14)70022-2. Epub 2014 Mar 4.

14.

Treatment outcome of multi-drug resistant tuberculosis in the United Kingdom: retrospective-prospective cohort study from 2004 to 2007.

Anderson LF, Tamne S, Watson JP, Cohen T, Mitnick C, Brown T, Drobniewski F, Abubakar I.

Euro Surveill. 2013 Oct 3;18(40). pii: 20601.

15.

A tale of two settings: the role of the Beijing genotype in the epidemiology of multidrug-resistant tuberculosis.

Stagg HR, Cohen T, Becerra MC, Anderson LF, Abubakar I.

Eur Respir J. 2014 Feb;43(2):632-5. doi: 10.1183/09031936.00140513. Epub 2013 Sep 13. No abstract available.

16.

Investigating transmission of Mycobacterium bovis in the United Kingdom in 2005 to 2008.

Mandal S, Bradshaw L, Anderson LF, Brown T, Evans JT, Drobniewski F, Smith G, Magee JG, Barrett A, Blatchford O, Laurenson IF, Seagar AL, Ruddy M, White PL, Myers R, Hawkey P, Abubakar I.

J Clin Microbiol. 2011 May;49(5):1943-50. doi: 10.1128/JCM.02299-10. Epub 2011 Mar 23.

17.

Trends in multidrug-resistant tuberculosis in Scotland, 2000-7.

Anderson LF, Laurenson IF, Blatchford O, Shakir E, McMenamin J, Johnston F, Stevenson J.

Euro Surveill. 2009 Mar 19;14(11). pii: 19149.

18.

The trypanocide diminazene aceturate is accumulated predominantly through the TbAT1 purine transporter: additional insights on diamidine resistance in african trypanosomes.

de Koning HP, Anderson LF, Stewart M, Burchmore RJ, Wallace LJ, Barrett MP.

Antimicrob Agents Chemother. 2004 May;48(5):1515-9.

19.

PTRAMP; a conserved Plasmodium thrombospondin-related apical merozoite protein.

Thompson J, Cooke RE, Moore S, Anderson LF, Janse CJ, Waters AP.

Mol Biochem Parasitol. 2004 Apr;134(2):225-32.

PMID:
15003842
20.

New drug screen assay uses fewer mice, while cutting costs.

Anderson LF.

J Natl Cancer Inst. 1995 Aug 16;87(16):1213-4. No abstract available.

PMID:
7563166
21.

Enthusiasm for quality-of-life research rises.

Anderson LF.

J Natl Cancer Inst. 1995 May 17;87(10):712-4. No abstract available.

PMID:
7563146
22.

Scientists grapple with silicones, breast implant research.

Anderson LF.

J Natl Cancer Inst. 1995 May 3;87(9):634-5. No abstract available.

PMID:
7752265
23.

The people who make cancer clinical trials happen.

Anderson LF.

J Natl Cancer Inst. 1995 Jan 18;87(2):81-3. No abstract available.

PMID:
7707394
24.

States strive to screen hard-to-reach women.

Anderson LF.

J Natl Cancer Inst. 1994 Dec 21;86(24):1825-7. No abstract available.

PMID:
7990156
25.

Issues raised on availability of breast cancer materials for research.

Anderson LF.

J Natl Cancer Inst. 1994 Nov 2;86(21):1580-2. No abstract available.

PMID:
7932821
26.

Large-scale effort tests digital mammography's potential.

Anderson LF.

J Natl Cancer Inst. 1994 Apr 20;86(8):580-2. No abstract available.

PMID:
8145271
27.

DDT and breast cancer: the verdict isn't in.

Anderson LF.

J Natl Cancer Inst. 1994 Apr 20;86(8):576-7. No abstract available.

PMID:
7702645
28.

Disease prevention research gains ground.

Anderson LF.

J Natl Cancer Inst. 1993 Nov 17;85(22):1802-3. No abstract available.

PMID:
8230259
29.

Scientists find new applications for cancer maps.

Anderson LF.

J Natl Cancer Inst. 1993 Jul 21;85(14):1111-2. No abstract available.

PMID:
8320738
30.

Cancer Act anniversary encourages reflection, new visions.

Anderson LF.

J Natl Cancer Inst. 1991 Dec 18;83(24):1795-6. No abstract available.

PMID:
1744923
31.

President's panel examines cancer among the poor.

Anderson LF.

J Natl Cancer Inst. 1991 Aug 7;83(15):1060. No abstract available.

PMID:
1875411
32.

New project begins testing ways to cut red tape.

Anderson LF.

J Natl Cancer Inst. 1989 Aug 16;81(16):1215-6. No abstract available.

PMID:
2754744
33.

Potential gene therapy for AIDS described.

Anderson LF.

J Natl Cancer Inst. 1989 Jul 19;81(14):1055-6. No abstract available.

PMID:
2786964
34.

Cancer and AIDS groups push for changes in drug approval process.

Anderson LF.

J Natl Cancer Inst. 1989 Jun 7;81(11):829-31. No abstract available.

PMID:
2724348
35.

White House physician Lee to be active in health policy.

Anderson LF.

J Natl Cancer Inst. 1989 May 3;81(9):659-60. No abstract available.

PMID:
2651676
36.

Realizing the benefits of an information system.

Anderson LF.

Healthc Financ Manage. 1983 Jun;37(6):38-9, 42-3. No abstract available.

PMID:
10315348
37.

Physiology and natural history of obesity.

Nelson RA, Anderson LF, Gastineau CF, Hayles AB, Stamnes CL.

JAMA. 1973 Feb 5;223(6):627-30. No abstract available.

PMID:
4739188

Supplemental Content

Loading ...
Support Center